Barakat, N.S. 2009. In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac. AAPS PharmSciTech 10: 724–731.
Ben Reguiga, M., L. Bonhomme-Faivre, and R. Farinotti. 2007. Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in rats. Journal of Pharmacy and Pharmacology 59: 401–408.
Chen, J., L. Qiu, M. Hu, Y. Jin, and J. Han. 2008. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel. Drug Development and Industrial Pharmacy 34: 588–594.
Choi, H.G., M.H. Kim, M.K. Lee, and C.K. Kim. 1999. Effect of additives on the physicochemical properties of liquid suppository. International Journal of Pharmaceutics 190: 13–19.
Choi, H.G., J.H. Jung, J.M. Ryu, S.J. Yoon, Y.K. Oh, and C.K. Kim. 1998. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. International Journal of Pharmaceutics 165: 33–44.
Choi, Y.K., D.W. Lee, C.S. Yong, H.G. Choi, T.K. Bronich, and J.O. Kim. 2011. Biostable Poly(ethylene oxide)-b-poly(methacrylic acid) micelles for pH-triggered release of doxorubicin. Journal of Pharmaceutical Investigation 41: 111–115.
Du, W., L. Hong, T. Yao, X. Yang, Q. He, B. Yang, and Y. Hu. 2007. Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid. Bioorganic & Medicinal Chemistry 15: 6323–6330.
Elsabahy, M., M.E. Perron, N. Bertrand, G.E. Yu, and J.C. Leroux. 2007. Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles. Biomacromolecules 8: 2250–2257.
Engels, F.K., R.A. Mathot, W.J. Loos, R.H. van Schaik, and J. Verweij. 2006. Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel. Cancer Biology & Therapy 5: 833–839.
Esmaeili, F., R. Dinarvand, M.H. Ghahremani, S.N. Ostad, H. Esmaily, and F. Atyabi. 2010. Cellular cytotoxicity and in vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles. Anti-Cancer Drugs 21: 43–52.
Esmaeili, F., R. Dinarvand, M.H. Ghahremani, M. Amini, H. Rouhani, N. Sepehri, S.N. Ostad, and F. Atyabi. 2009. Docetaxel-albumin conjugates, preparation, in vitro evaluation and biodistribution studies. Journal of Pharmaceutical Sciences 98: 2718–2730.
Gao, K., J. Sun, K. Liu, X. Liu, and Z. He. 2008. Preparation and characterization of a submicron lipid emulsion of docetaxel, submicron lipid emulsion of docetaxel. Drug Development and Industrial Pharmacy 34: 1227–1237.
Hu, K., S. Cao, F. Hu, and J. Feng. 2012. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles, preparation, in vitro, and in vivo evaluation. International Journal of Nanomedicine 7: 3537–3545.
Jun, Y.J. 2012. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile. International Journal of Pharmaceutics 422: 374–380.
Kintzel, P.E., L.B. Michaud, and M.K. Lange. 2006. Docetaxel-associated epiphora. Pharmacotherapy 26: 853–867.
Klueglich, M., A. Ring, S. Scheuerer, D. Trommeshauser, C. Schuijt, B. Liepold, and G. Berndl. 2005. Ibuprofen Extrudate, a Novel, Rapidly Dissolving Ibuprofen Formulation, Relative Bioavailability Compared to Ibuprofen Lysinate and Regular Ibuprofen, and Food Effect on All Formulations. Journal of Clinical Pharmacology 45: 1055–1061.
Malingré, M.M., D.J. Richel, J.H. Beijnen, H. Rosing, F.J. Koopman, W.W. Ten Bokkel Huinink, M.E. Schot, and J.H. Schellens. 2001. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. Journal of Clinical Oncology 19: 1160–1166.
Mayol, L., M. Biondi, F. Quaglia, S. Fusco, A. Borzacchiello, A.L. La, and M.I. Rotonda. 2011. Injectable thermally responsive mucoadhesive gel for sustained protein delivery. Biomacromolecules 12: 28–33.
Ryu, J.M., S.J. Chung, M.H. Lee, C.K. Kim, and C.K. Shim. 1999. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum. Journal of Controlled Release 59: 163–172.
Sakai, M., N. Hobara, N. Hokama, H. Kameya, S. Ohshiro, M. Sakanashi, and H. Saitoh. 2004. Increased bioavailability of tacrolimus after rectal administration in rats. Biological and Pharmaceutical Bulletin 27: 1480–1482.
Sambuelli, A.M., S.M. Negreira, A.H. Gil, S.P. Huernos, S. Goncalves, M.A. Toro, Z. Kogan, A. Cabanne, S. Camarero, J.C. Bai, and A.J. Lazarowski. 2006. Multidrug resistance gene (MDR-1) expression in the colonic mucosa of patients with refractory ulcerative colitis. Acta Gastroenterologica Latinoamericana 36: 23–32.
Seo, Y.G., D.W. Kim, W.H. Yeo, T. Ramasamy, Y.K. Oh, Y.J. Park, J.A. Kim, D.H. Oh, S.K. Ku, J.K. Kim, C.S. Yong, J.O. Kim, and H.G. Choi. 2013. Docetaxel-loaded thermosensitive and bioadhesive nanomicelles as a rectal drug delivery system for enhanced chemotherapeutic effect. Pharmaceutical Research 30(7): 1860–1870.
Straubinger, R.M., and S.V. Balasubramanian. 2005. Preparation and characterization of taxane-containing liposomes. Methods in Enzymology 391: 97–117.
Veyries, M.L., G. Couarraze, S. Geiger, F. Agnely, L. Massias, B. Kunzli, F. Faurisson, and B. Rouveix. 1999. Controlled release of vancomycin from poloxamer 407 gels. International Journal of Pharmaceutics 192: 183–193.
Wang, L., J. Dong, J. Chen, J. Eastoe, and X. Li. 2009. Design and optimization of a new self-nanoemulsifying drug delivery system. Journal of Colloid and Interface Science 330: 443–448.
Wils, P., V. Phung-Ba, A. Warnery, D. Lechardeur, S.D. Raeissi, I.J. Hidalgo, and D. Scherman. 1994. Polarized transport of docetaxel and vinblstine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochemical Pharmacology 48: 1528–1530.
Yan, Y.D., D.H. Kim, J.H. Sung, C.S. Yong, and H.G. Choi. 2010. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. International Journal of Pharmaceutics 399: 116–120.
Yang, Y., J. Wang, X. Zhang, W. Lu, and Q. Zhang. 2009. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. Journal of Controlled Release 135: 175–182.
Yin, Y.M., F.D. Cui, C.F. Mu, M.K. Choi, J.S. Kim, S.J. Chung, C.K. Shim, and D.D. Kim. 2009. Docetaxel microemulsion for enhanced oral bioavailability, preparation and in vitro and in vivo evaluation. J. Control. Rel. 140: 86–94.
Yong, C.S., J.S. Choi, Q.Z. Quan, J.D. Rhee, C.K. Kim, S.J. Lim, K.M. Kim, and H.G. Choi. 2001. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. International Journal of Pharmaceutics 226: 195–205.
Yong, C.S., C.H. Yang, J.D. Rhee, B.J. Lee, D.C. Kim, D.D. Kim, C.K. Kim, J.S. Choi, and H.G. Choi. 2004. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. International Journal of Pharmaceutics 269: 169–176.
Yuan, Y., C. Ying, Z. Li, Z.H. Ping, G.Y. Sha, Z. Bo, et al. 2012. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. International Journal of Pharmaceutics 430: 114–119.
Xuan, J.J., P. Balakrishnan, D.H. Oh, W.H. Yeo, S.M. Park, C.S. Yong, and H.G. Choi. 2010. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. The International Journal of Pharmaceutics 395: 317–323.
Zrieki, A., R. Farinotti, and M. Buyse. 2010. Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo. European Journal of Pharmacology 636: 189–197.